255 related articles for article (PubMed ID: 37456806)
1. COVID-19 mRNA vaccination is associated with IgA nephropathy: an analysis of the Japanese adverse drug event report database.
Nakao H; Koseki T; Kato K; Yamada S; Tsuboi N; Takahashi K; Mizuno T
J Pharm Pharm Sci; 2023; 26():11453. PubMed ID: 37456806
[No Abstract] [Full Text] [Related]
2. Analysis of COVID-19 mRNA Vaccine-induced Mouth Ulcers Using the Japanese Adverse Drug Event Report Database.
Onoda T; Tanaka H; Matsuo H; Takigawa M; Satoh M; Ishii T
Pharmazie; 2023 May; 78(5):63-66. PubMed ID: 37189267
[TBL] [Abstract][Full Text] [Related]
3. New-onset IgA nephropathy following COVID-19 vaccination.
Ma Y; Xu G
QJM; 2023 Feb; 116(1):26-39. PubMed ID: 35920797
[TBL] [Abstract][Full Text] [Related]
4. The Influence of the Rapid Increase in the Number of Adverse Event Reports for COVID-19 Vaccine on the Disproportionality Analysis Using JADER.
Yamaoka K; Fujiwara M; Uchida M; Uesawa Y; Shimizu T
In Vivo; 2023; 37(1):345-356. PubMed ID: 36593055
[TBL] [Abstract][Full Text] [Related]
5. Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance.
Ruggiero R; Balzano N; Di Napoli R; Mascolo A; Berrino PM; Rafaniello C; Sportiello L; Rossi F; Capuano A
Front Immunol; 2022; 13():956825. PubMed ID: 36177033
[TBL] [Abstract][Full Text] [Related]
6. Comparative safety profile of bivalent and original COVID-19 mRNA vaccines regarding myocarditis/pericarditis: A pharmacovigilance study.
Chen C; Chen C; Cao L; Fang J; Xiao J
Int Immunopharmacol; 2024 May; 133():112022. PubMed ID: 38615382
[TBL] [Abstract][Full Text] [Related]
7. IgA nephropathy with glomerular capillary IgA deposition following SARS-CoV-2 mRNA vaccination: a report of three cases.
Yokote S; Ueda H; Shimizu A; Okabe M; Yamamoto K; Tsuboi N; Yokoo T
CEN Case Rep; 2022 Nov; 11(4):499-505. PubMed ID: 35562631
[TBL] [Abstract][Full Text] [Related]
8. Molecular Pathogenic Mechanisms of IgA Nephropathy Secondary to COVID-19 mRNA Vaccination.
Wang L; Mao Z; Zhang L; Shao F
Kidney Blood Press Res; 2024; 49(1):144-154. PubMed ID: 38301615
[TBL] [Abstract][Full Text] [Related]
9. Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study.
Mascolo A; di Mauro G; Fraenza F; Gaio M; Zinzi A; Pentella C; Rossi F; Capuano A; Sportiello L
Front Immunol; 2022; 13():965171. PubMed ID: 36263025
[TBL] [Abstract][Full Text] [Related]
10. Sibling cases of gross hematuria and newly diagnosed IgA nephropathy following SARS-CoV-2 vaccination.
Uchiyama Y; Fukasawa H; Ishino Y; Nakagami D; Kaneko M; Yasuda H; Furuya R
BMC Nephrol; 2022 Jun; 23(1):216. PubMed ID: 35729514
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune disorders reported following COVID-19 vaccination: A disproportionality analysis using the WHO database.
Kim S; Bea S; Choe SA; Choi NK; Shin JY
Eur J Clin Pharmacol; 2024 Mar; 80(3):445-453. PubMed ID: 38212538
[TBL] [Abstract][Full Text] [Related]
12. Adverse Events Following COVID-19 Vaccination in Adolescents: Insights From Pharmacovigilance Study of VigiBase.
Kim DH; Kim JH; Oh IS; Choe YJ; Choe SA; Shin JY
J Korean Med Sci; 2024 Mar; 39(8):e76. PubMed ID: 38442719
[TBL] [Abstract][Full Text] [Related]
13. IgA nephropathy relapse following COVID-19 vaccination treated with corticosteroid therapy: case report.
Watanabe S; Zheng S; Rashidi A
BMC Nephrol; 2022 Apr; 23(1):135. PubMed ID: 35392838
[TBL] [Abstract][Full Text] [Related]
14. Secondary immunoglobulin A nephropathy with gross hematuria leading to rapidly progressive glomerulonephritis following severe acute respiratory syndrome coronavirus 2 vaccination: a case report.
Fukuda M; Kaneko T; Kawai T; Ishii H; Shimizu A
BMC Nephrol; 2023 Aug; 24(1):232. PubMed ID: 37553599
[TBL] [Abstract][Full Text] [Related]
15. Gross hematuria can be an impact of severe acute respiratory syndrome coronavirus 2 vaccination on immunoglobulin A nephropathy: a case report.
Kanamori H
J Med Case Rep; 2022 Jul; 16(1):273. PubMed ID: 35818083
[TBL] [Abstract][Full Text] [Related]
16. Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.
Kim JE; Park J; Min YG; Hong YH; Song TJ
J Peripher Nerv Syst; 2022 Sep; 27(3):206-214. PubMed ID: 35751472
[TBL] [Abstract][Full Text] [Related]
17. Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults.
Tompkins LK; Baggs J; Myers TR; Gee JM; Marquez PL; Kennedy SB; Peake D; Dua D; Hause AM; Strid P; Abara W; Rossetti R; Shimabukuro TT; Shay DK
Vaccine; 2022 Dec; 40(52):7653-7659. PubMed ID: 36372665
[TBL] [Abstract][Full Text] [Related]
18. IgA Nephropathy with Gross Hematuria Following COVID-19 mRNA Vaccination.
Nihei Y; Kishi M; Suzuki H; Koizumi A; Yoshida M; Hamaguchi S; Iwasaki M; Fukuda H; Takahara H; Kihara M; Tomita S; Suzuki Y
Intern Med; 2022 Apr; 61(7):1033-1037. PubMed ID: 35110484
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.
Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X
Front Immunol; 2021; 12():669010. PubMed ID: 34093567
[TBL] [Abstract][Full Text] [Related]
20. An adolescent girl diagnosed with IgA nephropathy following the first dose of the COVID-19 vaccine.
Okada M; Kikuchi E; Nagasawa M; Oshiba A; Shimoda M
CEN Case Rep; 2022 Aug; 11(3):376-379. PubMed ID: 35118635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
